Engineering radionuclide - labeled antibodies
Project goals
production of prototype radioimunological agent based on protein-engineered antibody with required combination of desirable properties
Keywords
Engineering radionuclide - labeled antibodiesradioimunological agentradoitherapyradionucleides
Public support
Provider
Ministry of Education, Youth and Sports
Programme
EUREKA - European co-operation in the sphere of applied and industrial research and development aimed at the support of multinational co-operation among industrial undertakings, research institutes and universities
Call for proposals
EUREKA 4 (SMSM200600OE1)
Main participants
—
Contest type
VS - Public tender
Contract ID
2469/2009-32
Alternative language
Project name in Czech
Proteinově-inženýrské protilátky značené radionuklidy
Annotation in Czech
produkce prototypového radioimunologického činidla založeného na proteinově-inženýrsky zkonstruované protilátce s potřebnou kombinací žádoucích vlastností
Scientific branches
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
Radiodinated proteins, especially antibodies are useful tools for targeting biological targets of diagnostic imaging and therapeutic interest. This project results is the subject of matter of invention. There is expected patent protection
Solution timeline
Realization period - beginning
Mar 1, 2006
Realization period - end
Dec 31, 2009
Project status
U - Finished project
Latest support payment
Mar 3, 2009
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP10-MSM-OE-U/01:1
Data delivery date
Jun 30, 2010
Finance
Total approved costs
18,186 thou. CZK
Public financial support
9,093 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
9,093 thou. CZK
Recognised costs
18 186 CZK thou.
Public support
9 093 CZK thou.
0%
Provider
Ministry of Education, Youth and Sports
CEP
EC - Immunology
Solution period
01. 03. 2006 - 31. 12. 2009